1/11/2023

Cetirizine Oral Solution

Products Affected - Description

- Cetirizine hydrochloride oral solution, Padagis, 1 mg/mL, 120 mL bottle, NDC 45802-0974-26 - discontinued
- Cetirizine hydrochloride oral solution, Padagis, 1 mg/mL, 120 mL bottle, NDC 45802-0626-26 - discontinued

Reason for the Shortage

- Camber has cetirizine oral solution available and is allocating supplies.
- Johnson & Johnson Consumer Healthcare has Children's Zyrtec Allergy oral solution available.
- Major has cetirizine oral solution available.
- Padagis has discontinued cetirizine oral solution.
- Additional over-the-counter cetirizine oral solution products may be available from store brands. These companies do not provide availability information.

Available Products

- Children's Zyrtec Allergy oral solution, Johnson & Johnson Consumer Healthcare, 1 mg/mL, 118 mL grape bottle, NDC 50580-0730-05
- Cetirizine hydrochloride oral solution, Camber, 1 mg/mL, 118 mL bottle, NDC 69230-0316-11
- Cetirizine hydrochloride oral solution, Major, 1 mg/mL, 118 mL bottle, NDC 00904-6765-20

Updated

Updated January 11, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 2, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.